Can a chemo drug save lungs in scleroderma patients?
NCT ID NCT01570764
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This study tested whether adding a strong immune-suppressing drug (cyclophosphamide) to standard prednisone can stop lung function from getting worse in people with scleroderma-related lung scarring. Forty adults with worsening lung function took part. The goal was to see if more patients could stabilize or improve their lung capacity after one year compared to those on prednisone alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cochin Hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.